#cancer-research

#cancer-research

Research on restoring fertility in childhood cancer survivors is underway, using sperm-producing stem cells.

Jaiwen Hsu is the first recipient of stem cells aimed at restoring fertility post-cancer.

A groundbreaking stem cell transplant offers hope for men with azoospermia, potentially restoring fertility after cancer treatment.

The rise in early-onset cancer is concerning, highlighting the need for better awareness and preventive measures.

Lifestyle factors may contribute significantly to the increasing rates of cancer in younger adults.

Trump's administration has paused critical funding for cancer research and medical projects, disrupting NIH operations and creating uncertainty in ongoing and future trials.

Colorectal cancer cases among individuals under 50 are rising, signaling a worrying trend that contradicts traditional perceptions of health and lifestyle.

Continued research funding is crucial for combating glioblastoma and other cancers, especially given recent budget cuts.

Exportin-1 plays a critical role in gene transcription in addition to its known function in nucleocytoplasmic transport.

Sylvie Beljanski champions natural cancer solutions through her foundation and innovative health products inspired by her father's groundbreaking research.

Sugary soda consumption is significantly linked to a higher risk of oral cancer in women.

Bowel cancer rates are rising among younger adults globally, with a 3.6% annual increase in England, necessitating awareness of early signs.

Cancer cells can transfer defective mitochondria to immune cells, leading to immune evasion.

Research reveals the previously unknown migration of mitochondria in human cells.

The research showcases collaboration across departments to study microbial pathogenesis and its role in diseases such as AIDS and cancer.

Genetically engineered mice were essential for studying immune responses in cancer research under ethical guidelines.

mRNA technology's success in COVID vaccines is paving the way for personalized cancer vaccines.

Personalized cancer treatment is advancing through technologies like genomic sequencing and AI, aiding early detection and potential vaccines.

Aspirin may disrupt cancer cell evasion mechanisms, aiding immune system response against them.

New research targets ecDNA to treat aggressive cancers and improve chemotherapy resistance.

Combining targeted therapies with traditional treatments enhances the fight against aggressive liver cancer, marking a significant therapeutic advancement.

The FDA has removed online resources related to diversity in clinical trials, affecting initiatives for inclusive drug evaluations.

Cuts to indirect funding may disrupt essential cancer research and clinical trials, negatively impacting patient outcomes.

Cancer incidence is increasing among younger adults, yet new drug trials often fail, highlighting the need for improved trial designs.

The Santa in the City event raises funds for Sarcoma UK, combining festive spirit with support for cancer research.

Band of Parents raises funds for neuroblastoma research to improve survival rates for children.

Awesome Games Done Quick 2025 raised over $2.5 million for the Prevent Cancer Foundation, continuing its legacy of impactful charity gaming.

AI and quantum computing can create novel anti-cancer drugs targeting previously untreatable proteins.

A breakthrough in cancer research identifies a critical protein for chordoma treatment, offering new hope for effective therapies.

New therapies for cancer may disrupt disease growth through innovative molecular glues and insights into genetic mutations.

Cancer understanding has evolved to include not just genetic mutations but also epigenetic changes that influence gene expression.

Cancer development is influenced by both genetic mutations and epigenetic changes, highlighting the complexity of treatment and understanding.

Earli aims to revolutionize early cancer detection through innovative science and technology.

Bhad Bhabie's $BHAD token emphasizes transparency and community, aiming to support cancer research and engage fans meaningfully.

Ribosome profiling revealed the existence of 'dark proteins' produced from previously unknown genomic regions.

Semaglutide significantly alleviates obesity-related knee arthritis pain, matching the efficacy of painkillers.

Advanced mapping of tumor cells offers crucial insights for cancer treatment development.

New findings on protocell structures may shed light on the evolution of cell membranes.

Mitochondria are dynamic and complex structures, not just bean-shaped, challenging traditional perceptions.

Reid Hoffman advocates that AI enhances human capabilities and overcomes information challenges.

Manas AI, co-founded by Reid Hoffman, is an AI-driven startup focusing on drug discovery for major cancers, raising $24.6 million in seed funding.

Mutant RAS genes contribute to tumor growth through mechanisms in the nucleus, not just cell surface signaling.

NIH cancels key meetings, raising concerns among researchers about the impact on vital biomedical research.

A new AI model, General Expression Transformer (GET), predicts gene behavior, aiding in understanding cancer and genetic diseases.

The development of a comprehensive catalog of transcription factor binding sites enhances the understanding of gene regulation related to cancer and developmental disorders.

Global variations in promotion criteria for professorship can hinder researchers' career prospects, highlighting the need for equitable hiring practices.

Metformin works by reducing the cell's energy supply by interfering with mitochondria, a key discovery on its mechanism of action in lowering blood sugar.

Advancements in spatial omics are revolutionizing how researchers understand tumor heterogeneity, enabling visualization and classification of diverse cell types within tumors.

Tumors evolve similarly to species, adapting and changing over time, which poses challenges for treatment and prognosis.

The event honors Stuart Scott, raising awareness of racial disparities in cancer research and treatment, promoting vibrant living in the face of cancer.

The event honors Stuart Scott's legacy while focusing on alleviating racial disparities in cancer research and treatment.

Dr. Brian Druker resigns as CEO of OHSU's Knight Cancer Institute due to mission misalignment, yet he will continue his research and patient care.

Dr. Brian Druker steps down due to concerns about OHSU's commitment to its mission.

The author's diagnosis led to a significant life change, focusing on health and cancer research.

Susan Wojcicki's final message focused on lung cancer awareness and personal reflections on her diagnosis, urging better funding for cancer research.

Three-dimensional cancer atlases provide groundbreaking insights into tumor structures and interactions, paving the way for new cancer research and treatments.

Tumor development, spread, and treatment responses are better understood through new insights from the Human Tumor Atlas Network studies.